Weeks after launching its first open call for diabetes advocates, Dexcom is spotlighting the resulting group of 16 people in ...
DexCom's growth rate has been improving, but that hasn't been enough of a reason for investors to buy up the stock.
DexCom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is ...
Morgan Stanley lowered the firm’s price target on DexCom (DXCM) to $63 from $89 and keeps an Overweight rating on the shares. Published first on ...
Barchart on MSN
DexCom Stock: Is Wall Street Bullish or Bearish?
DexCom, Inc. (DXCM), headquartered in San Diego, California, is a leading medical-device company that designs, develops and ...
A trio of stocks made an impressive leap in their Benzinga Edge value scores this week, with one standout making a 138% jump.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback